担心
发表于 2025-3-30 11:35:29
COVID-19: Molecular Pathogenesis and Prospective Therapeutic Interventions, the world health organization (WHO). The pathogen (SARS-CoV-2) targets the epithelial cells of the respiratory system, resulting in diffuse alveolar damage. Here, in this chapter, we have comprehensively reviewed the information regarding SARS-CoV-2 infections, its molecular basis of pathogenesis,
异常
发表于 2025-3-30 12:35:23
Exploring the Link Between Malaria and COVID-19,th limited per capita income..As the discussion in this article will show, the difference in the prevalence of COVID-19 among populations is correlated uneven propagation of the ACEI/D and the ACE2 (C1173T substitution) polymorphisms. The similarity of presentations between . and COVID-19 and the po
JOT
发表于 2025-3-30 19:31:14
The Use of Azithromycin and Lopinavir-Ritonavir in the Treatment of COVID-19,hrough both in vitro and clinical trials; the results of which have confirmed its potential application as part of COVID-19 treatment therapy. In vitro tests conducted on Vero cells indicated that a combination of lopinavir/ritonavir and azithromycin is highly effective in inhibiting viral replicati
污秽
发表于 2025-3-31 00:32:37
Current Strategies to Combat COVID-19,he article. Currently used therapeutics for COVID-19 like remdesivir, chloroquine, and hydroxychloroquine, lopinavir/ritonavir, ribavirin, favipiravir, Arbidol, convalescent plasma therapy are discussed.
conscribe
发表于 2025-3-31 04:08:45
Phytomolecules and Novel Drug Delivery Approach for COVID-19, natural phytoconstituents are efficient home remedies for COVID-19 therapy for quick recovery and immune modulators as a preventive measure. In this chapter, we’ve discussed the value of natural substances in the treatment of COVID-19 as well as contemporary integrated pharmaceutical therapies that
Exposure
发表于 2025-3-31 07:20:08
http://reply.papertrans.cn/99/9832/983185/983185_56.png
歌剧等
发表于 2025-3-31 09:32:56
http://reply.papertrans.cn/99/9832/983185/983185_57.png
排他
发表于 2025-3-31 16:27:21
http://reply.papertrans.cn/99/9832/983185/983185_58.png